BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone; Drug: Montelukast Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
Effectiveness of Point-of-care Lung Ultrasound for the Management of Childhood Lower Respiratory Infections
Conditions: Lower Respiratory Infection; LRTI; Pneumonia; Bronchiolitis Interventions: Diagnostic Test: Point-of-care lung ultrasound; Diagnostic Test: Chest X-ray (digital images) Sponsors: Nagasaki University; London School of Hygiene and Tropical Medicine; Siddhi Memorial Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials